Skip to main content

〈 Back to All News

NIDA has just published a set of seven new funding opportunities


NIDA has just published a set of HIV/DA FOAs designed under the 'Racial Equity Initiative | National Institute on Drug Abuse (NIDA).' Click the links below to learn more about each of these 7 different opportunities.

1. New Funding Opportunity: RFA-DA-23-024: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional) (nih.gov)
A letter of intent is due October 14, 2022. Applications are due November 14, 2022.

2. New Funding Opportunity: RFA-DA-23-023: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional) (nih.gov)
A letter of intent is due October 14, 2022. Applications are due November 14, 2022.

3. New Funding Opportunity: RFA-DA-23-013: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) (nih.gov)
A letter of intent is due October 14, 2022. Applications are due November 14, 2022.

4. New Funding Opportunity: RFA-DA-23-032: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)
A letter of intent is due October 14, 2022. Applications are due November 14, 2022.

5. New Funding Opportunity:RFA-DA-23-028: NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) (nih.gov)
A letter of intent is due October 14, 2022. Applications are due November 14, 2022.

6. New Funding Opportunity: RFA-DA-23-029: NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) (nih.gov)
A letter of intent is due October 14, 2022. Applications are due November 14, 2022.

7. New Funding Opportunity: RFA-DA-23-025: NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed) (nih.gov)
A letter of intent is due October 15, 2022. Applications are due November 15, 2022.